Bio-Rad Laboratories Total Assets 2006-2020 | BIO.B

Bio-Rad Laboratories total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Bio-Rad Laboratories total assets for the quarter ending March 31, 2020 were $8.684B, a 26.54% increase year-over-year.
  • Bio-Rad Laboratories total assets for 2019 were $8.009B, a 42.73% increase from 2018.
  • Bio-Rad Laboratories total assets for 2018 were $5.611B, a 31.31% increase from 2017.
  • Bio-Rad Laboratories total assets for 2017 were $4.273B, a 10.97% increase from 2016.
Bio-Rad Laboratories Annual Total Assets
(Millions of US $)
2019 $8,009
2018 $5,611
2017 $4,273
2016 $3,851
2015 $3,710
2014 $3,341
2013 $3,389
2012 $3,444
2011 $3,097
2010 $3,063
2009 $2,536
2008 $2,037
2007 $1,972
2006 $1,596
2005 $1,427
Bio-Rad Laboratories Quarterly Total Assets
(Millions of US $)
2020-03-31 $8,684
2019-12-31 $8,009
2019-09-30 $7,177
2019-06-30 $7,647
2019-03-31 $6,863
2018-12-31 $5,611
2018-09-30 $6,719
2018-06-30 $6,386
2018-03-31 $6,215
2017-12-31 $4,273
2017-09-30 $4,186
2017-06-30 $4,143
2017-03-31 $3,953
2016-12-31 $3,851
2016-09-30 $4,020
2016-06-30 $3,875
2016-03-31 $3,753
2015-12-31 $3,710
2015-09-30 $3,666
2015-06-30 $3,525
2015-03-31 $3,326
2014-12-31 $3,341
2014-09-30 $3,386
2014-06-30 $3,468
2014-03-31 $3,441
2013-12-31 $3,389
2013-09-30 $3,280
2013-06-30 $3,483
2013-03-31 $3,457
2012-12-31 $3,444
2012-09-30 $3,303
2012-06-30 $3,169
2012-03-31 $3,188
2011-12-31 $3,097
2011-09-30 $2,970
2011-06-30 $3,044
2011-03-31 $2,909
2010-12-31 $3,063
2010-09-30 $2,682
2010-06-30 $2,527
2010-03-31 $2,547
2009-12-31 $2,536
2009-09-30 $2,478
2009-06-30 $2,344
2009-03-31 $1,955
2008-12-31 $2,037
2008-09-30 $2,015
2008-06-30 $2,099
2008-03-31 $2,053
2007-12-31 $1,972
2007-09-30 $1,712
2007-06-30 $1,655
2007-03-31 $1,607
2006-12-31 $1,596
2006-09-30 $1,524
2006-06-30 $1,494
2006-03-31 $1,415
2005-12-31 $1,427
2005-09-30 $1,426
2005-06-30 $1,393
2005-03-31 $1,399
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.825B $2.312B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.603B 14.49
Gilead Sciences (GILD) United States $91.895B 11.91
CSL (CSLLY) Australia $89.448B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.705B 50.67
Regeneron Pharmaceuticals (REGN) United States $67.954B 26.19
Illumina (ILMN) United States $53.809B 55.29
Biogen (BIIB) United States $49.423B 8.46
Seattle Genetics (SGEN) United States $27.838B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.678B 11.03
Moderna (MRNA) United States $22.225B 0.00
Incyte (INCY) United States $21.933B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.590B 177.59
Genmab (GMAB) Denmark $19.447B 16.02
Genmab (GNMSF) Denmark $18.331B 54.42
Alnylam Pharmaceuticals (ALNY) United States $15.939B 0.00
BeiGene (BGNE) Cayman Islands $13.019B 0.00
Exact Sciences (EXAS) United States $12.913B 0.00
Galapagos (GLPG) Belgium $12.822B 37.97
BioNTech SE (BNTX) Germany $11.852B 0.00
Sarepta Therapeutics (SRPT) United States $11.776B 0.00
Bio-Techne Corp (TECH) United States $10.085B 66.63
QIAGEN (QGEN) Netherlands $10.007B 29.10
ARGENX SE-ADR (ARGX) Netherlands $9.958B 0.00
Horizon Therapeutics Public (HZNP) Ireland $9.606B 23.64
Guardant Health (GH) United States $8.264B 0.00
Immunomedics (IMMU) United States $7.717B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.484B 0.00
Exelixis (EXEL) United States $7.443B 26.10
Ascendis Pharma (ASND) Denmark $7.006B 0.00
Repligen (RGEN) United States $6.976B 122.36
Acceleron Pharma (XLRN) United States $5.215B 0.00
Adaptive Biotechnologies (ADPT) United States $4.926B 0.00
MyoKardia (MYOK) United States $4.854B 0.00
Emergent Biosolutions (EBS) United States $4.682B 30.69
Reata Pharmaceuticals (RETA) United States $4.664B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.479B 0.00
Zai Lab (ZLAB) China $4.416B 0.00
Mirati Therapeutics (MRTX) United States $4.386B 0.00
Vir Biotechnology (VIR) United States $4.366B 0.00
China Biologic Products (CBPO) China $4.330B 24.07
MorphoSys AG (MOR) Germany $4.284B 33.22
Global Blood Therapeutics (GBT) United States $4.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.171B 91.15
Blueprint Medicines (BPMC) United States $3.832B 0.00
Bluebird Bio (BLUE) United States $3.625B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.609B 0.00
Arena Pharmaceuticals (ARNA) United States $3.434B 0.00
Amicus Therapeutics (FOLD) United States $3.386B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.314B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Denali Therapeutics (DNLI) United States $3.001B 0.00
UniQure (QURE) Netherlands $2.919B 0.00
Novavax (NVAX) United States $2.877B 0.00
NeoGenomics (NEO) United States $2.766B 202.00
Insmed (INSM) United States $2.689B 0.00
Viela Bio (VIE) United States $2.660B 0.00
Alkermes (ALKS) Ireland $2.653B 52.22
Amarin (AMRN) Ireland $2.633B 0.00
Alector (ALEC) United States $2.600B 0.00
Fate Therapeutics (FATE) United States $2.484B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.483B 0.00
Inovio Pharmaceuticals (INO) United States $2.267B 0.00
Principia Biopharma (PRNB) United States $2.109B 0.00
Eidos Therapeutics (EIDX) United States $1.900B 0.00
Ligand Pharmaceuticals (LGND) United States $1.778B 69.23
Zymeworks (ZYME) Canada $1.770B 0.00
Epizyme (EPZM) United States $1.765B 0.00
Adverum Biotechnologies (ADVM) United States $1.696B 0.00
Sangamo Therapeutics (SGMO) United States $1.662B 0.00
Twist Bioscience (TWST) United States $1.595B 0.00
Arcus Biosciences (RCUS) United States $1.590B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.574B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.571B 0.00
Editas Medicine (EDIT) United States $1.552B 0.00
Akcea Therapeutics (AKCA) United States $1.525B 0.00
Mesoblast (MESO) Australia $1.524B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Beam Therapeutics (BEAM) United States $1.444B 0.00
Intra-Cellular Therapies (ITCI) United States $1.425B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Zealand Pharma (ZEAL) Denmark $1.410B 0.00
REGENXBIO (RGNX) United States $1.398B 0.00
NGM Biopharmaceuticals (NGM) United States $1.388B 0.00
Coherus BioSciences (CHRS) United States $1.359B 9.49
Mersana Therapeutics (MRSN) United States $1.282B 0.00
Arvinas (ARVN) United States $1.277B 0.00
I-Mab (IMAB) China $1.260B 0.00
Cytokineticsorporated (CYTK) United States $1.255B 0.00
Revance Therapeutics (RVNC) United States $1.217B 0.00
Compugen (CGEN) Israel $1.149B 0.00
Myriad Genetics (MYGN) United States $1.147B 59.19
Intellia Therapeutics (NTLA) United States $1.041B 0.00
Sorrento Therapeutics (SRNE) United States $1.000B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.969B 0.00
Athenex (ATNX) United States $0.969B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.937B 0.00
Pharming Group (PHGUF) Netherlands $0.895B 0.00
Cue Biopharma (CUE) United States $0.874B 0.00
Heska (HSKA) United States $0.814B 0.00
Cellectis S.A (CLLS) France $0.809B 0.00
Alcobra (ARCT) United States $0.799B 0.00
NextCure (NXTC) United States $0.789B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.773B 0.00
Codexis (CDXS) United States $0.754B 0.00
Kala Pharmaceuticals (KALA) United States $0.753B 0.00
Cara Therapeutics (CARA) United States $0.742B 0.00
Kadmon Holdings (KDMN) United States $0.741B 0.00
NantKwest (NK) United States $0.738B 0.00
Retrophin (RTRX) United States $0.726B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.713B 0.00
Agenus (AGEN) United States $0.681B 0.00
Intrexon (PGEN) United States $0.676B 0.00
Vericel (VCEL) United States $0.672B 124.08
ZIOPHARM Oncology Inc (ZIOP) United States $0.669B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Dynavax Technologies (DVAX) United States $0.662B 0.00
Bellus Health (BLU) Canada $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Morphic Holding (MORF) United States $0.635B 0.00
Stemline Therapeutics (STML) United States $0.627B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.622B 5.33
Athersys (ATHX) United States $0.613B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.605B 0.00
Frequency Therapeutics (FREQ) United States $0.578B 0.00
AnaptysBio (ANAB) United States $0.555B 0.00
DBV Technologies S.A (DBVT) France $0.544B 0.00
Cel-Sci (CVM) United States $0.543B 0.00
Clovis Oncology (CLVS) United States $0.537B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
MeiraGTx Holdings (MGTX) United States $0.517B 0.00
Scholar Rock Holding (SRRK) United States $0.514B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.513B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.510B 0.00
VBI Vaccines (VBIV) United States $0.496B 0.00
Anika Therapeutics (ANIK) United States $0.495B 15.91
BioDelivery Sciences (BDSI) United States $0.477B 25.10
AC Immune SA (ACIU) Switzerland $0.474B 0.00
Protagonist Therapeutics (PTGX) United States $0.460B 0.00
Prothena (PRTA) Ireland $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.452B 0.00
Syros Pharmaceuticals (SYRS) United States $0.443B 0.00
Puma Biotechnology (PBYI) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.422B 0.00
Albireo Pharma (ALBO) United States $0.411B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.403B 0.00
Precision BioSciences (DTIL) United States $0.400B 0.00
MiMedx (MDXG) United States $0.398B 0.00
Seres Therapeutics (MCRB) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.378B 324.00
CytomX Therapeutics (CTMX) United States $0.373B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 7.26
Avid Bioservices (CDMO) United States $0.356B 0.00
Kamada (KMDA) Israel $0.337B 14.00
Selecta Biosciences (SELB) United States $0.334B 0.00
WAVE Life Sciences (WVE) Singapore $0.334B 0.00
Geron (GERN) United States $0.333B 0.00
OSMOTICA PHARM (OSMT) United States $0.325B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.315B 0.00
Verastem (VSTM) United States $0.307B 0.00
MannKind (MNKD) United States $0.307B 0.00
Menlo Therapeutics (MNLO) United States $0.304B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.292B 0.00
ChromaDex (CDXC) United States $0.291B 0.00
Liquidia Technologies (LQDA) United States $0.287B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.264B 0.00
Affimed (AFMD) Germany $0.263B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Cellular Biomedicine (CBMG) United States $0.256B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Pfenex (PFNX) United States $0.255B 0.00
HOOKIPA Pharma (HOOK) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
XOMA (XOMA) United States $0.249B 0.00
Prometic Life Sciences (LMNL) Canada $0.246B 0.00
Exicure (XCUR) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Northwest Biotherapeutics (NWBO) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
IVERIC Bio (ISEE) United States $0.211B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
ARAVIVE, INC (ARAV) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
GENFIT S.A (GNFT) France $0.199B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.198B 0.00
VTv Therapeutics (VTVT) United States $0.196B 0.00
IBio (IBIO) United States $0.194B 0.00
Five Prime Therapeutics (FPRX) United States $0.193B 0.00
Pluristem Therapeutics (PSTI) Israel $0.191B 0.00
Kindred Biosciences (KIN) United States $0.189B 0.00
Aytu Bioscience (AYTU) United States $0.186B 0.00
Strongbridge Biopharma (SBBP) United States $0.185B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
TELA Bio (TELA) United States $0.177B 0.00
Cerecor (CERC) United States $0.174B 0.00
Dyadic (DYAI) United States $0.169B 0.00
Orgenesis (ORGS) United States $0.169B 0.00
Aptinyx (APTX) United States $0.163B 0.00
Celyad SA (CYAD) Belgium $0.163B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Cidara Therapeutics (CDTX) United States $0.151B 0.00
Trevena (TRVN) United States $0.147B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Arbutus Biopharma (ABUS) Canada $0.144B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Theratechnologies (THTX) Canada $0.140B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.132B 0.00
VolitionRX (VNRX) United States $0.131B 0.00
Applied Genetic Technologies (AGTC) United States $0.128B 0.00
Palatin Technologies (PTN) United States $0.128B 3.28
AVEO Pharmaceuticals (AVEO) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.122B 0.00
AIT Therapeutics (XAIR) United States $0.118B 0.00
Oncobiologics (OTLK) United States $0.118B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.113B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Protalix BioTherapeutics (PLX) Israel $0.111B 0.00
Eton Pharmaceuticals (ETON) United States $0.108B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Catalyst Biosciences (CBIO) United States $0.093B 0.00
Organovo Holdings (ONVO) United States $0.091B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
SESEN BIO, INC (SESN) United States $0.085B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Celsion (CLSN) United States $0.081B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Proteostasis Therapeutics (PTI) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.069B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Signal Genetics (MGEN) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Celldex Therapeutics (CLDX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.050B 0.00
Cocrystal Pharma (COCP) United States $0.049B 0.00
Advaxis (ADXS) United States $0.046B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.046B 0.00
Prima BioMed (IMMP) Australia $0.046B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
OvaScience (MLND) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cesca Therapeutics (THMO) United States $0.042B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
TrovaGene (CRDF) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
TOCAGEN INC (TOCA) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.030B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Spherix (AIKI) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00